The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy.
Tang
Jianming
J
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Kaslow
Richard A
RA
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D016207:Cytokines / Q000235:genetics; D018450:Disease Progression; D019450:Genes, MDR / Q000235:genetics; D005805:Genes, MHC Class I / Q000235:genetics; D016679:Genome, Viral; D015658:HIV Infections / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics; D006801:Humans; D008024:Ligands; D019707:Receptors, Chemokine / Q000235:genetics
D016207:Cytokines; D015235:HLA-B Antigens; C103707:HLA-B57 antigen; D008024:Ligands; D019707:Receptors, Chemokine